期刊文献+

紫杉醇和多西紫杉醇双药胶束体外稳定性考察 被引量:6

In vitro stability of paclitaxel and docetaxel binary-drug loaded micelles
下载PDF
导出
摘要 对紫杉醇和多西紫杉醇双药胶束稳定性进行了研究。用聚乙二醇单甲醚-聚乳酸嵌段共聚物(mPEG-PLA)同时增溶紫杉醇和多西紫杉醇,并对比考察体外稳定性的变化。当药物质量浓度为1 mg/mL、载药率为10%时,紫杉醇和多西紫杉醇单药胶束(single-drug loaded micelles,SDM)分别在9 h和1 h内稳定;当两种药物的载药率都为25%时,双药胶束(binary-drug loaded micelles,BDM)稳定性能超过24 h。此外,双药胶束在高浓度(≥1 mg/mL)时比低浓度(0.04 mg/mL)更加稳定。双药胶束用透射电镜观察,发现了一种网状结构。体外药物释放实验表明,双药胶束的释药速度比单药胶束快。双药胶束作为一种高载药率和高稳定性的载药形式,是胶束设计的一个新的选择。 The binary-drug loaded micelles(BDM),in which paclitaxel(PTX) and docetaxel(DTX) co-solubilized with the monomethoxy poly(ethylene glycol)-block-poly(D,L-lactide)(mPEG-PLA) copolymer,were prepared and evaluated for their in vitro stability.It was found that the stabilities of paclitaxel and docetaxel single-drug loaded micelles(SDM) with a drug-loading content of 10% maintained in the period of 9 h and 1 h,respectively,whereas the stable period of BDM with both drug-loading content of 25% was up to 24 h.Moreover,the BDM showed better physical stability at high drug concentration(≥1 mg/mL) than low concentration(0.04 mg/mL).In addition,a network structure of the BDM was observed using transmission electron microscopy(TEM).Faster in vitro release of paclitaxel and/or docetaxel from the BDM was found if compared with those of SDM.BDM in the potentials such as high drug-loading content and excellent stability might be an alternative to the micelles design.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2010年第5期428-434,共7页 Journal of China Pharmaceutical University
基金 国家科技支撑计划资助项目(No.2008BAT55B03) 国家"重大新药创制"科技重大专项资助项目(No.2009zx09310-004)~~
关键词 胶束 稳定性 聚乙二醇单甲醚 聚乳酸 紫杉醇 多西紫杉醇 micelles stability mPEG PLA paclitaxel docetaxel
  • 相关文献

参考文献21

  • 1Eschalier A,Lavarenne J, Burtin C,et al. Study of histamine release induced by acute administration of antitumor agents in dogs [J]. Caneer Chemother Pharmacol, 1988,21 ( 3 ) :246 - 250.
  • 2van Zuylen L,Verweij J,Sparreboom A. Role of formulation vehicles in taxane pharmacology [J]. Invest New Drugs, 2001,19 (2) :125 -141.
  • 3Kim SC,Yoon HJ,Lee JW,et al. Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles [ J ]. Int J Pharm,2005,293 ( 1/2 ) : 303 - 310.
  • 4Donyai P, Sewell GJ. Physical and chemical stability of paclitaxel infusions in different container types[J]. J Oncol Pharm Pract, 2006,12(4) :211 -222.
  • 5Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol [ J ]. Int J Pharm, 1996,132 ( 2 ) : 195 - 206.
  • 6Lee KS, Chung HC, hn SA,et al. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel,in patients with metastatic breast cancer [ J 1. Breast Cancer Res Treat,2008,108 ( 2 ) :241 - 250.
  • 7Kim DW, Kim SY,Kim HK,et al. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non- smail-cell lung cancer [ J ]. Ann. Oncol, 2007,18 ( 12 ) : 2 009 - 2 014.
  • 8Kim TY, Kim DW, Chung JY,et al. Phase I and pharmaeokinetic study of Genexol-PM, a cremophor-free,polymeric micelle-formulated paclitaxel,in patients with advanced malignancies[J]. Clin Cancer Res,2004,10 ( 11 ) :3 708 - 3 716.
  • 9Lim WT,Tan EH,Toh CK,et al. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors [J]. Ann Oneol, 2009,21 ( 2 ) : 382 -388.
  • 10Kim SC,Yoon H J, Lee JW,et al. Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles[J]. Int J Pharm,2005,293(1/2) :303 - 310.

二级参考文献14

  • 1张晓庆,刘明忠,张利斌.注射用多西他赛与不同溶媒配伍稳定性的研究[J].药学服务与研究,2007,7(2):150-151. 被引量:8
  • 2Cortes J, Rodriguez J, Aramendia J, et al. Front-line paclitaxel/ cisplatin-based chemotherapy in brainmetastases from non-small- cell lung cancer[ J]. Oncology,2003 ,64( 1 ) :28 - 35.
  • 3Hammad MA ,Muller BW. Increasing drug solubility by means of bile sah-phosphatidylcholine-based mixed micelles [ J ]. Eur J Pharm Biopharm, 1998,46 ( 3 ) :361 - 367.
  • 4Hammad MA , MUller BW. Solubility and stability of tetrazepam in mixed micelles [ J ]. Eur J Pharm Sci, 1998,7 ( 1 ) :49 - 55.
  • 5Hammad MA, Muller BW. Solubility and stability of clonazepam in mixed micelles[ J]. Int J Pharm,1998,169( 1 ) :55 -64.
  • 6Yanasarn N, Sloat BR, Cui Z. Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel[ J]. Int J Pharm,2009,379( 1 ) : 174 - 180.
  • 7梁文权(LiangWQ).生物药剂学与药物动力学[M].2版.北京:人民卫生出版社,2003:37.
  • 8Desai N, Trieu V, Yang A, et al. Enhanced efficacy and safety of nanoparticle albumin-bound nab-docetaxel versus taxotere [ J ]. Proc Amer Assoc Cancer Res ,2006,47 : 1 277 - 1 278.
  • 9刘平,孙伟.高效液相色谱法测定熊胆痔疮膏中牛磺熊去氧胆酸钠的含量[J].中国药师,2008,11(2):199-201. 被引量:7
  • 10季冬英,吴琼珠,平其能.PLA-mPEG的合成和多西紫杉醇聚合物胶束的制备[J].中国药科大学学报,2008,39(3):223-227. 被引量:13

共引文献3

同被引文献64

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部